Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction

Journal of the American College of Cardiology

Volumn 45, Issue 7, 2005, Pages 999-1002

  Timmer, Jorik R ^a   Ottervanger, Jan Paul ^a   De Boer, Menko Jan ^a   Dambrink, Jan Henk E ^a   Hoorntje, Jan C A ^a   Gosselink, A T Marcel ^a   Suryapranata, Harry ^a   Zijlstra, Felix ^b   Van't Hof, Arnoud W J ^a  

^a ISALA HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TIROFIBAN;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY THROMBOSIS; CORONARY RISK; DISEASE ASSOCIATION; EPICARDIUM; FEMALE; GENERAL CONDITION IMPROVEMENT; HEART INFARCTION; HEART MUSCLE REPERFUSION; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; OBSERVATION; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; TREATMENT OUTCOME;

EID: 15944403234     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.12.050     Document Type: Article

References (13)

1. G.W. Stone, D. Cox, E. Garcia Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials Circulation 6 2001 636 641
2. C.P. Cannon Importance of TIMI 3 flow Circulation 104 2001 624 626
3. N.N. Wahab, E.A. Cowden, N.J. Pearce, M.J. Gardner, H. Merry, J.L. Cox ICONS Investigators Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 40 2002 1748 1754
4. A.W.J. van't Hof, N. Ernst, M.J. de Boer Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial Eur Heart J 25 2004 837 846
5. TIMI Study Group The Thrombolysis In Myocardial Infarction (TIMI) trial Phase I findings N Engl J Med 312 1985 932 936
6. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care 26 Suppl 1 2003 S5 S20
7. B.A. Mizock Alterations in fuel metabolism in critical illness: hyperglycaemia Best Pract Res Clin Endocrinol Metab 15 2001 533 551
8. P. Gresele, G. Guglielmini, M. De Angelis Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus J Am Coll Cardiol 41 2003 1013 1020
9. R. Marfella, M. Siniscalchi, K. Esposito Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome Diabetes Care 26 2003 3129 3135
10. K. Esposito, F. Nappo, R. Marfella Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress Circulation 106 2002 2067 2072
11. C.T. Esmon Inflammation and thrombosis J Thromb Haemost 1 2003 1343 1348
12. B.G. Angeja, J. de Lemos, S.A. Murphy Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy Am Heart J 144 2002 649 656
13. N.M. Ernst, H. Suryapranata, K. Miedema Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction J Am Coll Cardiol 44 2004 1187 1193